American Depositary Receipt. Zai Lab Limited is a foreign issuer that files on a foreign accounting basis, so its per-share figures and ratios are not directly comparable to US-listed companies. Invest Viable does not provide an Investment Score for ADRs, and reports cannot be built on them. You can still use the Valuator to run your own valuation.
NASDAQ
ZLAB
Last Price
US $21.03
Updated
November 20, 2026
LAST PRICE
$21.03
Nov 20, 2026 · Close
Profit margin
-38.15%
Profit margin
Current Ratio
2.4:1
Current Ratio
D/E: 0.47
Capital Returns
-31.11%
Return on equity
ROIC: -31.72%
Valuation History
-
Price to Earnings
EV/EBITDA: -10.7X
Cash flow
-151M
Annual operating cash flow
Profit margin
-38.15%
Profit margin
KEY FIGURES
MKT CAP
$2.4B
EPS
TTM-$1.76
EPS Growth (1Y)
-38.46%
PEG
TTM-
P/E
TTM-
P/S
TTM5.35x
YIELD
-
GROWTH (5Y CAGR)
Revenue
56.54%
EBITDA
13.43%
Cash flow
6.66%
Base Cash Flow Valuation (DCF)
Fair Value
Market $21.03
—
Default assumptions
Base EBITDA Valuation
Fair Value
Market $21.03
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.
Overall, Zai Lab Limited scores 42 out of 100, indicating Mixed fundamentals.
Valuation
Zai Lab Limited fails most valuation checks. The stock price is high relative to current fundamentals across nearly every metric evaluated. Review the valuation checks (#1–#8) for the specific results.
Financial Strength
The balance sheet is generally sound, with most financial strength checks passing. One or two areas fall short of the strongest thresholds but do not indicate distress. Review the financial checks (#9–#16) for specifics.
Business Performance
Multiple performance checks have failed, indicating weakening operations across revenue growth, profitability, or returns on capital. Review the performance checks (#17–#28) for the specific concerns.
Strong balance sheet, but weak operations and an elevated stock price. Financial strength provides downside protection, but performance (#17–#28) and valuation (#1–#8) are both weak. The stock price relies on expectations not yet visible in operating results.
Valuation
Financial
Performance